M. van der Graaff

465 total citations
24 papers, 232 citations indexed

About

M. van der Graaff is a scholar working on Pharmacology, Oncology and Molecular Biology. According to data from OpenAlex, M. van der Graaff has authored 24 papers receiving a total of 232 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pharmacology, 6 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in M. van der Graaff's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Metabolism and Genetic Disorders (5 papers). M. van der Graaff is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (6 papers) and Metabolism and Genetic Disorders (5 papers). M. van der Graaff collaborates with scholars based in Netherlands, United States and United Kingdom. M. van der Graaff's co-authors include Nico Vermeulen, J. K. Boeijinga, D. D. Breimer, R. Jochemsen, D.D. Breimer, Pim N.J. Langendijk, Wim Goettsch, Elisabeth George, Beate Wieseler and Anna Bucsics and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, Journal of Neurology Neurosurgery & Psychiatry and Biochemical Pharmacology.

In The Last Decade

M. van der Graaff

23 papers receiving 227 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. van der Graaff Netherlands 9 81 38 37 37 33 24 232
J. K. Boeijinga Netherlands 8 125 1.5× 47 1.2× 36 1.0× 61 1.6× 57 1.7× 13 348
Lloyd Stevens United Kingdom 10 47 0.6× 11 0.3× 74 2.0× 27 0.7× 34 1.0× 16 323
Masako Asoh Japan 9 166 2.0× 31 0.8× 60 1.6× 117 3.2× 92 2.8× 16 373
Barton Cobert United States 9 259 3.2× 23 0.6× 72 1.9× 27 0.7× 129 3.9× 14 545
Tillement Jp France 11 76 0.9× 16 0.4× 118 3.2× 41 1.1× 62 1.9× 72 381
Sarah F. Cook United States 8 122 1.5× 17 0.4× 37 1.0× 62 1.7× 37 1.1× 15 304
Evangelia Eirini Tsermpini Greece 12 193 2.4× 11 0.3× 104 2.8× 76 2.1× 26 0.8× 26 552
Chiaki Kawanishi Japan 11 121 1.5× 9 0.2× 80 2.2× 33 0.9× 34 1.0× 19 333
Bo Lumholtz Denmark 9 42 0.5× 49 1.3× 41 1.1× 42 1.1× 19 0.6× 11 364
Juhana E. Idänpään-Heikkilä United States 11 24 0.3× 31 0.8× 53 1.4× 142 3.8× 24 0.7× 21 407

Countries citing papers authored by M. van der Graaff

Since Specialization
Citations

This map shows the geographic impact of M. van der Graaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. van der Graaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. van der Graaff more than expected).

Fields of papers citing papers by M. van der Graaff

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. van der Graaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. van der Graaff. The network helps show where M. van der Graaff may publish in the future.

Co-authorship network of co-authors of M. van der Graaff

This figure shows the co-authorship network connecting the top 25 collaborators of M. van der Graaff. A scholar is included among the top collaborators of M. van der Graaff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. van der Graaff. M. van der Graaff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vulto, Arnold G., M. van der Graaff, Steven Simoens, et al.. (2020). Sustainability of Biosimilars in Europe: A Delphi Panel Consensus with Systematic Literature Review. Pharmaceuticals. 13(11). 400–400. 7 indexed citations
2.
Huić, Mirjana, Elisabeth George, Beate Wieseler, et al.. (2015). European collaboration on relative effectiveness assessments: What is needed to be successful?. Health Policy. 119(5). 569–576. 20 indexed citations
3.
Graaff, M. van der, Teaco Kuiper, Aeilko H. Zwinderman, et al.. (2009). Clinical Identification of Dysarthria Types among Neurologists, Residents in Neurology and Speech Therapists. European Neurology. 61(5). 295–300. 13 indexed citations
4.
Graaff, M. van der, et al.. (2002). An unusual cause of epilepsy and mental deterioration. British Journal of Radiology. 75(896). 709–710. 1 indexed citations
5.
Graaff, M. van der, et al.. (1997). Status epilepticus due to a ruptured dermoid cyst.. Journal of Neurology Neurosurgery & Psychiatry. 62(3). 222–222. 7 indexed citations
6.
Graaff, M. van der, Nico Vermeulen, & D. D. Breimer. (1988). Disposition of hexobarbital: 15 years of an intriguing model substrate. Drug Metabolism Reviews. 19(2). 109–164. 10 indexed citations
7.
Vermeulen, Nico, W. Onkenhout, M. van der Graaff, & A. G. L. Burm. (1987). Glass capillary glc ms applications in the analysis of drugs and metabolites in biological fluids. 337077186. 1 indexed citations
8.
Graaff, M. van der, Nico Vermeulen, & D.D. Breimer. (1986). Intra-arterial administration of hexobarbital enantiomers to the rat: disposition and estimation of apparent extraction ratio. Pharmacy World & Science. 8(2). 139–144. 1 indexed citations
9.
Graaff, M. van der, et al.. (1986). Correlation between the metabolism of hexobarbital and aminopyrinein vivoin rats. Xenobiotica. 16(12). 1091–1096. 4 indexed citations
10.
Graaff, M. van der, et al.. (1986). Dose-dependent pharmacokinetics of zoxazolamine in the rat.. Drug Metabolism and Disposition. 14(3). 331–335. 5 indexed citations
11.
Graaff, M. van der, et al.. (1986). Stereospecific analysis of racemic hexobarbital in rat blood by enantioselective capillary gas chromatography. Journal of Chromatography B Biomedical Sciences and Applications. 375(2). 411–415. 4 indexed citations
12.
Graaff, M. van der, et al.. (1986). The influence of pretreatment on the urinary metabolite profile of pseudoracemic hexobarbital. Biochemical Pharmacology. 35(18). 3166–3169. 1 indexed citations
13.
Graaff, M. van der, et al.. (1986). Pharmacokinetics of orally administered hexobarbital in plasma and saliva of healthy subjects. Biopharmaceutics & Drug Disposition. 7(3). 265–272. 11 indexed citations
14.
Graaff, M. van der, et al.. (1986). Non-linear pharmacokinetics of sparteine in the rat.. PubMed. 282(2). 181–95.
15.
Graaff, M. van der, Nico Vermeulen, & D. D. Breimer. (1985). Route- and dose-dependent pharmacokinetics of hexobarbitone in the rat: a re-evaluation of the use of sleeping times in metabolic studies. Journal of Pharmacy and Pharmacology. 37(8). 550–554. 8 indexed citations
16.
Graaff, M. van der, et al.. (1984). Correlation between the in vivo Metabolism of Hexobarbital and Antipyrine in Rats with a Portacaval Shunt. Pharmacology. 29(2). 99–109. 4 indexed citations
17.
Graaff, M. van der, et al.. (1983). Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats.. Journal of Pharmacology and Experimental Therapeutics. 227(2). 459–465. 23 indexed citations
18.
Graaff, M. van der, et al.. (1983). Disposition of hexobarbital enantiomers in the rat.. Drug Metabolism and Disposition. 11(5). 489–493. 13 indexed citations
19.
Graaff, M. van der, Nico Vermeulen, Pim N.J. Langendijk, & D. D. Breimer. (1983). Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies.. Journal of Pharmacology and Experimental Therapeutics. 225(3). 747–751. 17 indexed citations
20.
Jochemsen, R., et al.. (1982). Influence of sex, menstrual cycle and oral contraception on the disposition of nitrazepam.. British Journal of Clinical Pharmacology. 13(3). 319–324. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. K. Boeijinga Breakdown of academic impact, for papers by Lloyd Stevens Breakdown of academic impact, for papers by Masako Asoh Breakdown of academic impact, for papers by Barton Cobert Breakdown of academic impact, for papers by Tillement Jp Breakdown of academic impact, for papers by Sarah F. Cook Breakdown of academic impact, for papers by Evangelia Eirini Tsermpini Breakdown of academic impact, for papers by Chiaki Kawanishi Breakdown of academic impact, for papers by Bo Lumholtz Breakdown of academic impact, for papers by Juhana E. Idänpään-Heikkilä
Rankless by CCL
2026